- (November 2017). "New
antituberculous drugs derived from
natural products:
current perspectives and
issues in
antituberculous drug development". The...
-
Albert Calmette 1863-1933:
founder of
antivenomous serotherapy and of
antituberculous BCG vaccination". Toxicon. 37 (9): 1241–58. doi:10.1016/s0041-0101(99)00086-0...
- corticosteroids,
immune modulators. Antibiotics, antifungals, antileprotics,
antituberculous drugs, antimalarials, anthelmintics, amoebicides, antivirals, antiprotozoals...
- the most frequent. However, a
majority of
patients improve following antituberculous treatment.
Rarely lymphangitic spread of lung
cancer could mimic miliary...
- gene
encoding pyrazinamidase/nicotinamidase,
cause resistance to the
antituberculous drug
pyrazinamide in
tubercle bacillus".
Nature Medicine. 2 (6): 662–667...
- PMID 6386028.
Ormerod LP,
Horsfield N (July 1987). "Short-course
antituberculous chemotherapy for
pulmonary and
pleural disease: 5 years' experience...
-
complications of BCG vaccination, but
potentially life-threatening.
Systemic antituberculous therapy may be
helpful in
severe complications. When BCG is used for...
-
Testing Susceptibility of
Mycobacterium tuberculosis to Four
Major Antituberculous Drugs:
Comparison with the
Radiometric BACTEC 460TB
Method and the...
- gene
encoding pyrazinamidase/nicotinamidase,
cause resistance to the
antituberculous drug
pyrazinamide in
tubercle bacillus". Nat. Med. 2 (6): 662–7. doi:10...
-
Reviews 8.2 (2007): 148–154. Print. Verma, Indu, and Ajay Grover. "
Antituberculous Vaccine Development: A
Perspective For The
Endemic World."
Expert Review...
